Five people who had the Arcturus strain of Covid have died, according to the latest data from public health chiefs. As of 17 April, there were 105 cases of XBB.1.16 – also known as Arcturus – in ...

The new Arcturus variant of COVID-19 had claimed five lives in the UK as of April 17, with 120 infections recorded. Arcturus is now present in over 30 countries. Cases of the new variant have been ...

Infectious disease experts and public health officials alike are on alert since the World Health Organization (WHO) announced a new COVID-19 variant of interest, XBB.1.16, also known as Arcturus. WHO ...

A new coronavirus variant is making headlines around the world, causing cases to rise and prompting warnings from scientists that it could soon be the dominant strain. The Arcturus variant has led to ...

This comes after five people died from the new strain which has reached all four UK nations. According to the most recent briefing from the UK Health and Security Agency (UKHSA), there have already ...

Since the pandemic began more than three years ago, numerous variants have emerged as the virus that causes COVID-19 evolved. As the COVID public health emergency ends, case numbers drop and concerns ...

A new subvariant of the coronavirus has been gaining steam in recent weeks, and it has spread to several countries, including the United States. The XBB.1.16 subvariant, a member of the omicron ...

New Covid strain XBB.1.18, nicknamed arcturus, is quickly spreading across the U.S., but experts are warning that pink eye and high fever, two symptoms of the new variant, are particularly present ...

Coronavirus levels in Los Angeles County wastewater have ticked up, potentially as a result of the arrival of a more infectious Omicron subvariant dubbed Arcturus. The latest strain, known officially ...

The article provides an investment overview of Arcutus, offering insights and analysis, and ways of thinking about the investment opportunity. Arcutus is an mRNA specialist developer with no approved ...

A dwindling COVID-19 vaccine market is not stopping Arcturus Therapeutics from pressing ahead with its own mRNA candidate, as the biotech touts new early data indicating its shot lights up the immune ...